Table 1 Main characteristic of the patient cohorts included in the analysis and time points of the dose rate and whole-body activity measurements
From: External radiation exposure, excretion, and effective half-life in 177Lu-PSMA-targeted therapies
Department 1 | Department 2 | |
|---|---|---|
Mean age | 71.4 ± 9.2 years | 70.3 ± 8.3 years |
Mean activity | 6.1 ± 0.5 GBq | 6.6 ± 0.9 GBq |
Time points t i of the dose rate measurement | 4, 24, and 48 h p. i. | 2, 24, 48, and 72 h p. i. |
Time points t j of the whole-body activity measurement | Before the first bladder voiding and 2, 4, 12, 24, 48, and 72 h p. i. |